Provided by Tiger Trade Technology Pte. Ltd.

Xeris Pharmaceuticals Inc

8.74
+0.04000.46%
Post-market: 8.70-0.0400-0.46%19:30 EDT
Volume:870.74K
Turnover:7.59M
Market Cap:1.59B
PE:-85.68
High:8.80
Open:8.66
Low:8.54
Close:8.70
52wk High:10.08
52wk Low:5.25
Shares:182.32M
Float Shares:172.57M
Volume Ratio:0.47
T/O Rate:0.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1020
EPS(LYR):0.0032
ROE:-617.16%
ROA:6.13%
PB:-163.70
PE(LYR):2,725.29

Loading ...

Apr 10, 2020

Major Issues Report

Current report, items 5.02 and 9.01
Mar 12, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 12, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Mar 11, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Mar 10, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 21, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Major Issues Report

Current report, items 1.01, 8.01, and 9.01
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 11, 2020

Major Issues Report

Current report, items 2.02 and 8.01
Feb 07, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jan 10, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Nov 08, 2019

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Nov 07, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 07, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Oct 01, 2019

Major Issues Report

Current report, items 5.02 and 9.01
Sep 10, 2019

Major Issues Report

Current report, items 1.01, 2.03, 8.01, and 9.01
Aug 19, 2019

Correspondence

[Cover]Correspondence